CO47 Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Among Patients with Heart Failure with Preserved Ejection Fraction: A Real-World Study

M. Riaz,S. Smith,D.E. Winchester, J. Guo,E. Dietrich, H. Park

Value in Health（2023）

引用 0|浏览4

暂无评分

摘要

Compared with canagliflozin or dapagliflozin use, empagliflozin use was associated with decreased risk of HF-related and all-cause hospitalizations. Compared with canagliflozin, dapagliflozin was associated with a reduced risk of HF-related and all-cause hospitalizations.

查看译文

关键词

heart failure,ejection fraction,preserved ejection fraction,inhibitors,sodium-glucose,real-world

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要